Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries
- PMID: 21721000
- DOI: 10.1002/cncr.26323
Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries
Abstract
Background: Endometrial cancer (EC) is the most common extraintestinal malignancy in Lynch syndrome (LS) and often is the sentinel malignancy, yet there is no consensus regarding LS-EC detection algorithms. In this study, the authors determined the efficacy of family/personal history and tumor morphology in predicting LS in a cohort of patients with EC who had mutation-proven LS.
Methods: Amsterdam II (AmII) criteria, revised Bethesda guidelines (rBG), and Society of Gynecologic Oncologists (SGO) clinical screening criteria were applied to the pedigrees of 76 patients with mutation-proven LS who had pathology-proven EC. When tumors were tested for microsatellite instability (MSI) phenotype status or mismatch-repair protein-immunohistochemical (MMR-IHC) expression, those results also were reviewed, and LS-associated histopathologic features were documented in 38 available patients.
Results: Of 76 patients, 36%, 58%, 71%, and 93% would have been selected for further testing for LS by pedigree screening at the time of EC diagnosis with rBG, AmII, SGO 20%-to-25%, and SGO 5%-to-10% criteria, respectively. Ninety percent (18 of 20 tumors) of tested ECs had high MSI, and 96% (22 of 23 tumors) had abnormal MMR-IHC expression. At least 1 LS-EC morphologic feature was present in 16 of 38 tumors (42%).
Conclusions: Clinical screening criteria had variable efficacy for the identification of LS-associated EC, and SGO 5%-to-10% criteria performed best. Characteristic pathologic features were present in a minority of patients. Although a high proportion of LS-ECs had the MSI phenotype and were MMR deficient, the specificity of these tests and of clinical screening for LS in unselected patients with EC has been poorly described. Prospective studies to determine the optimal combination of these screening modalities are required.
Copyright © 2011 American Cancer Society.
Similar articles
-
Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.J Clin Oncol. 2015 Dec 20;33(36):4301-8. doi: 10.1200/JCO.2015.63.9518. Epub 2015 Nov 9. J Clin Oncol. 2015. PMID: 26552419 Free PMC article.
-
Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.Am J Surg Pathol. 2014 Jun;38(6):793-800. doi: 10.1097/PAS.0000000000000177. Am J Surg Pathol. 2014. PMID: 24503759
-
The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy.Am J Surg Pathol. 2014 Sep;38(9):1173-81. doi: 10.1097/PAS.0000000000000298. Am J Surg Pathol. 2014. PMID: 25025451
-
Identifying Lynch syndrome in patients with endometrial carcinoma: shortcomings of morphologic and clinical schemas.Adv Anat Pathol. 2012 Jul;19(4):231-8. doi: 10.1097/PAP.0b013e31825c6b76. Adv Anat Pathol. 2012. PMID: 22692286 Review.
-
[Lynch syndrome-related endometrial carcinoma].Zhonghua Bing Li Xue Za Zhi. 2012 Jul;41(7):494-7. doi: 10.3760/cma.j.issn.0529-5807.2012.07.018. Zhonghua Bing Li Xue Za Zhi. 2012. PMID: 22932468 Review. Chinese. No abstract available.
Cited by
-
An Analysis of Clinical, Surgical, Pathological and Molecular Characteristics of Endometrial Cancer According to Mismatch Repair Status. A Multidisciplinary Approach.Int J Mol Sci. 2020 Sep 29;21(19):7188. doi: 10.3390/ijms21197188. Int J Mol Sci. 2020. PMID: 33003368 Free PMC article.
-
International Society of Gynecological Pathologists (ISGyP) Endometrial Cancer Project: Guidelines From the Special Techniques and Ancillary Studies Group.Int J Gynecol Pathol. 2019 Jan;38 Suppl 1(Iss 1 Suppl 1):S114-S122. doi: 10.1097/PGP.0000000000000496. Int J Gynecol Pathol. 2019. PMID: 29521846 Free PMC article.
-
Lynch syndrome related endometrial cancer: clinical significance beyond the endometrium.J Hematol Oncol. 2013 Mar 25;6:22. doi: 10.1186/1756-8722-6-22. J Hematol Oncol. 2013. PMID: 23531335 Free PMC article.
-
Genetic testing strategies in newly diagnosed endometrial cancer patients aimed at reducing morbidity or mortality from lynch syndrome in the index case or her relatives.PLoS Curr. 2013 Sep 16;5:ecurrents.eogt.b59a6e84f27c536e50db4e46aa26309c. doi: 10.1371/currents.eogt.b59a6e84f27c536e50db4e46aa26309c. PLoS Curr. 2013. PMID: 24056992 Free PMC article.
-
Consequences of universal MSI/IHC in screening ENDOMETRIAL cancer patients for Lynch syndrome.Gynecol Oncol. 2014 Aug;134(2):319-25. doi: 10.1016/j.ygyno.2014.06.009. Epub 2014 Jun 14. Gynecol Oncol. 2014. PMID: 24933100 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources